Press release
Viscosupplementation Market Sales and Opportunity Analysis 2019 | Anika Therapeutics Inc., Sanofi S.A., Zimmer Biomet Holdings Inc., Bioventus LLC, Ferring B.V., Seikagaku Corporation
The expanding aging population is a major driving factor driving the viscosupplementation market. Age is an important risk factor for osteoarthritis, and epidemiological studies demonstrate a rise in the prevalence of osteoarthritis with growing age. According to CDC, the prevalence of osteoarthritis was found to be the highest in populations aged between 65 and 75 years. Viscosupplementation emerges as a prior and cost-effective treatment option to delay total knee replacement surgery, which is another major factor propelling the growth of the viscosupplementation market. Cost-analysis studies have shown that viscosupplementation delays the need to perform knee replacement by 2.6 years.
Reimbursement cutbacks are among the major factors that are expected to hamper the growth of the viscosupplementation market. American Association of Orthopedic Surgeons (AAOS) revised the long-standing clinical practice guideline for hyaluronic acid injection in May 2013, after which AAOS cannot recommend hyaluronic acid injection for patients with symptomatic knee osteoarthritis. Due to the AAOS response, most of the reimbursement payers continue deny reimbursements for hyaluronic acid injections. Moreover, the failure of clinical studies and the unavailability of FDA-approved hyaluronic acid injections for joints other than the knees are expected to restrain the growth of the viscosupplementation market.
Request to Download a Sample Copy of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9509
Market in China to Demonstrate Significant Growth
The global viscosupplementation market has been studied based on the product type and end user. Based on the product type, the viscosupplementation market has been segmented into three-injection viscosupplementation, single-injection viscosupplementation, and five-injection viscosupplementation. The three-injection viscosupplementation segment is expected to hold the maximum market share in the global viscosupplementation market.
Based on end user, the viscosupplementation market has been segmented into hospitals, orthopedic clinics, and ambulatory surgery centers. In terms of revenue, the hospital segment of the viscosupplementation market dominated the global viscosupplementation market in 2018.
North America is expected to dominate the global viscosupplementation market. Although developed countries dominate the market, emerging markets represent higher growth opportunities for the viscosupplementation market. For instance, China is expected to witness the highest growth rate in the viscosupplementation market over the forecast period. Factors, such as rising healthcare facilities and disposable income, are expected to significantly boost the demand for viscosupplementation in the near future.
Manufacturers to Strategize on New Product Launches
Manufacturers in the viscosupplementation market follow different strategies to grow their businesses as well as to penetrate the viscosupplementation market. Viscosupplementation market players are focusing on distribution and marketing agreements to enhance their market presence. For example market players such as Anika therapeutic, Bioventus LLC, Seikagaku Corporation, and Zimmer Biomet are focusing on distribution agreements for global market expansion. For instance, DePuy Mitek, Inc. has been distributing Anika Therapeutic's Orthovisc and Monovisc viscosupplementation products for a long period. In addition, in 2018, Seikagaku Corporation extended its distribution agreement with Bioventus LLC for the distribution of its five injections hyaluronic acid product Supartz FX in the U.S.
Manufacturers are focusing on the launch of new products in the U.S. market. Moreover, they are making efforts to receive approval for their hyaluronic acid-based products for the treatment of other types of joints, apart from the knees, in the U.S. market. Anika Therapeutics, Inc. is focusing on receiving FDA approval for its Cingal, hyaluronic acid, and corticosteroid combination injection.
Need more information about Report methodology @ https://www.futuremarketinsights.com/askus/rep-gb-9509
Some of the key players operating in viscosupplementation market are Anika Therapeutics Inc., Sanofi S.A., Zimmer Biomet Holdings Inc., Bioventus LLC, Ferring B.V., Seikagaku Corporation, Seikagaku Corporation, Chugai Pharmaceutical Co., Ltd., and Mylan N.V.
Viscosupplementation Market Reports - Table of Contents
1. Executive Summary
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
4. Key Success Factors
5. Global Viscosupplementation Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Global Viscosupplementation Market - Pricing Analysis
7. Global Viscosupplementation Market Demand (Volume in Units) Analysis 2014-2018 and Forecast, 2019-2029
7.1. Historical Market Volume (Units) Analysis, 2014-2018
7.2. Current and Future Market Volume (Units) Projections, 2019-2029
7.2.1. Y-o-Y Growth Trend Analysis
8. Market Background
8.1. Macro-Economic Factors
8.1.1. Global GDP Growth Outlook
8.1.2. Global Healthcare Expenditure Outlook
8.1.3. Per-Capita Healthcare Expenditure
8.2. Forecast Factors - Relevance & Impact
8.2.1. Top Companies Historical Growth
8.2.2. Increasing Ageing Population and Rising Obesity Rate
8.2.3. Ease of Treatment in Outpatient Basis
8.2.4. Cost Effectiveness
8.2.5. Rising Prevalence of Arthritis
8.3. Market Dynamics
8.3.1. Drivers
8.3.2. Restraints
8.3.3. Opportunity Analysis
9. Global Viscosupplementation Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 - 2018
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 - 2019
9.3.1. Single Injection Viscosupplementation
9.3.2. Three Injection Viscosupplementation
9.3.3. Five Injection Viscosupplementation
9.4. Market Attractiveness Analysis By Product Type
10. Global Viscosupplementation Market Analysis 2014-2018 and Forecast 2019-2029, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 - 2018
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019 - 2019
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Orthopedic Clinics
10.4. Market Attractiveness Analysis By End User
To Know More Information about This Report, Ask The Analyst: https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-9509
About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.
Contact Us
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: https://www.futuremarketinsights.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Viscosupplementation Market Sales and Opportunity Analysis 2019 | Anika Therapeutics Inc., Sanofi S.A., Zimmer Biomet Holdings Inc., Bioventus LLC, Ferring B.V., Seikagaku Corporation here
News-ID: 1762851 • Views: …
More Releases from Future Market Insights
Freeze Dried Fruits Market to Double by 2035 Driven by Health Trends, Innovation …
The global freeze-dried fruits market is projected to nearly double in size, rising from USD 9.97 billion in 2025 to USD 20.18 billion by 2035. This steady growth, supported by a compound annual growth rate (CAGR) of 7.3%, reflects the evolving consumer shift toward convenient, nutritious, and long-lasting food options. With busy lifestyles and heightened health awareness shaping food choices, freeze-dried fruits are gaining widespread popularity as they preserve flavor,…
Sourdough Market Set to Flourish, Rising from USD 5.9 Billion in 2025 to USD 10. …
The global sourdough market is entering a transformative decade, projected to grow at a CAGR of 6.8% between 2025 and 2035. Market size is set to increase from USD 5.9 billion in 2025 to USD 10.2 billion by 2035, reflecting a powerful consumer shift toward naturally fermented, clean-label, and artisanal bakery products. Sourdough is no longer confined to traditional bread-it has evolved into a global phenomenon embraced for its flavor,…
Probiotic Ingredients Market to Hit USD 12 Billion by 2035 Fueled by Gut Health …
The global probiotic ingredients market is entering a dynamic growth phase, with its value expected to rise from USD 8 billion in 2025 to USD 12 billion by 2035. This steady trajectory, projected at a CAGR of 3.3%, reflects the increasing global emphasis on digestive health and overall wellness. Consumers are turning to probiotics as trusted, science-backed solutions incorporated into everyday diets, fueling demand across food, beverage, and supplement categories.
Bacterial…
Global Fortified Yeast Market Projected to Expand at 13.5% CAGR to USD 447.0 Mil …
The global fortified yeast market is on an impressive growth trajectory, with the sector estimated to be valued at USD 190.2 million in 2024 and projected to reach USD 447.0 million by 2034, expanding at a CAGR of 13.5% during the forecast period.
This surge is driven by increasing consumer demand for nutrient-dense foods, advancements in biotechnology, and the expansion of fortified yeast applications across food, pharmaceuticals, and animal nutrition…
More Releases for Viscosupplementation
Viscosupplementation Market Report, History and Forecast 2023-2031
Newark, New Castle, USA - Growth Plus Reports has published a new report on Viscosupplementation Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Viscosupplementation provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive and statistical…
Hampering the growth of the viscosupplementation market 2021
Viscosupplementation is a minimally invasive procedure that involves injection of the hyaluronic acid injected into a knee joint to promote better joint development and lubrication. It also helps in reducing pain, irritation and helps in improving osteoarthritis condition. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Increasing prevalence of osteoarthritis in people is expected to boost…
Understanding Impact of COVID-19 on Viscosupplementation Market
According to the report, the global viscosupplementation market was valued at ~US$ 2.6 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Viscosupplementation can be performed using three primary injection types: single injection, three injections, and five injections. Applications of viscosupplementation injection include knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis. Growth of the global viscosupplementation market can be attributed to rise in…
The three injection viscosupplementation product type segment is projected to be …
Russia’s healthcare infrastructure will continue witnessing significant rise in number of orthopaedic patients as several bone & joint-related disorders are likely to be caused by people’s eating & drink habits, their proactive lifestyles and the country’s harsh weather conditions. Rising occurrence of joint-related ailments such as knee osteoarthritis in Russia are a result of people performing physical labour in severely cold weather conditions. This has necessitated the adoption of viscosupplementation…
Viscosupplementation Market
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia…
Viscosupplementation Market: Three Injection Viscosupplementation Likely to be t …
The rising obesity rate, coupled with an increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population and this is the precise reason for the rise in demand for viscosupplementation market. Considering this fact, a new market report titled “Viscosupplementation Market: Russia…
